Llwytho...
Acquired and intrinsic resistance in cancer immunotherapy
A number of immunotherapies, in particular immune checkpoint targeting antibodies and adoptive T‐cell therapies, are starting to transform the treatment of advanced cancers. The likelihood to respond to these immunotherapies differs strongly across tumor types, with response rates for checkpoint tar...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Oncol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528612/ https://ncbi.nlm.nih.gov/pubmed/25106088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.07.011 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|